share_log

News Highlights: Top company news of the day

News Highlights: Top company news of the day

新聞要點:公司當天的頭條新聞
Dow Jones ·  2022/05/04 11:21

Uber Revenue More Than Doubles

優步收入翻了一番以上

The company's revenue rose to $6.85 billion in its latest quarter, as demand for rides rebounded from last year's downturn due to Covid-19 and food delivery grew despite restaurant reopenings.

該公司最近一個季度的收入增至68.5億美元,原因是新冠肺炎導致的打車需求從去年的低迷中反彈,儘管餐廳重新開業,但外賣業務仍有所增長。

Marriott Sales Soar on Surging Travel Demand

萬豪酒店銷售額飆升,旅遊需求激增

The company reported an 81% jump in first-quarter sales to $4.2 billion.

該公司報告稱,第一季度銷售額躍升81%,至42億美元。

CVS Sales Up 11%, Lifted by Vaccine, Test-Kit Demand

CVS銷售額增長11%,受疫苗和檢測試劑盒需求提振

CVS logged $76.83 billion in revenue in the first quarter, as consumers scooped up take-home Covid-19 test kits.

由於消費者購買了帶回家的新冠肺炎測試套件,CVS在第一季度實現了768.3億美元的收入。

GrubHub Parent Just Eat Probes Senior Executive Over Misconduct Complaint

GRubHub母公司Just Eat調查高管不當行為投訴

The food-delivery company said it had launched an investigation into its chief operating officer over a complaint about possible personal misconduct at a company event.

這家外賣公司表示,已對其首席運營官展開調查,原因是有人投訴稱,該公司可能在一次活動中存在個人不當行為。

Tupperware Stock Tumbles After Guidance Withdrawn

特百惠庫存在指導被撤回後暴跌

The company pulls its outlook amid higher costs and other problems, and says its turnaround will take longer than expected

在更高的成本和其他問題下,該公司調高了前景,並表示其扭虧為盈的時間將比預期的更長

Ukraine War, Wordle Help New York Times Draw More Subscribers

烏克蘭戰爭,Wordle幫助《紐約時報》吸引更多訂户

The news company's profit dropped 89% on Athletic-related acquisition costs.

由於與體育相關的收購成本,新聞公司的利潤下降了89%。

Walgreens Names Heads of Marketing, Merchandising and Product

沃爾格林任命營銷、銷售和產品主管

The drugstore chain tapped the former marketing chief of Calvin Klein as its new CMO and named two other senior executives to support its expanded healthcare strategy.

這家藥店連鎖店任命卡爾文·克萊恩(Calvin Klein)前營銷主管為新的首席營銷官,並任命了另外兩名高管,以支持其擴大的醫療戰略。

Moderna Revenue Triples on Soaring Vaccine Sales

疫苗銷量飆升,Moderna收入翻了兩番

The biotechnology company's revenue topped $6 billion in its latest quarter, beating analyst expectations, driven almost entirely by sales of its mRNA-based vaccine.

這家生物技術公司在最近一個季度的收入超過了60億美元,超出了分析師的預期,這幾乎完全是由其基於mRNA的疫苗的銷售推動的。

Biogen Faces Tough Rebuild After Ditching Troubled Alzheimer's Drug

生物遺傳公司在放棄陷入困境的阿爾茨海默氏症藥物後面臨艱難重建

The biotech's best prospect is another drug for Alzheimer's now in development, but success is far from assured.

生物技術最有希望的是另一種治療阿爾茨海默氏症的藥物,目前正在研發中,但成功還遠未確定。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論